Literature DB >> 33754090

Limb Salvage Resection of Massive Dedifferentiated Thigh Liposarcoma in a Patient Lost to Follow-Up.

Nicholas J Calvo1, Adam J Mann1, Miguel Lopez-Viego1,2, Thomas Genuit1.   

Abstract

Dedifferentiated liposarcoma (DDL) is a rare soft tissue tumor that represents a non-lipogenic progression of well-differentiated liposarcoma (WDL). Unlike WDL, DDL has the propensity for metastasis and is associated with an increased incidence of local recurrence. For DDL of the extremities that is resectable with acceptable functional outcomes, treatment includes primary surgical resection with negative margins. Although rare due to advances in reconstructive techniques, amputation for DDL of the extremities should be considered in which appropriate tumor resection cannot be performed without adequate preservation of limb function. We present the clinical progression of a patient with a large DDL of the right thigh who was initially lost to follow-up, but ultimately underwent delayed definitive therapy with the intent for limb salvage. This case illustrates the importance of assessing neurovascular, osseous, and soft tissue involvement to properly predict and preserve limb function while achieving adequate tumor resection.
Copyright © 2021, Calvo et al.

Entities:  

Keywords:  dedifferentiated extremity liposarcoma; dedifferentiated liposarcoma; extremity liposarcoma; limb-salvage surgery; soft tissue sarcoma; well-differentiated liposarcoma

Year:  2021        PMID: 33754090      PMCID: PMC7971712          DOI: 10.7759/cureus.13356

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  16 in total

1.  Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.

Authors:  Alessandro Gronchi; Paola Collini; Rosalba Miceli; Barbara Valeri; Salvatore L Renne; Gianpaolo Dagrada; Marco Fiore; Roberta Sanfilippo; Marta Barisella; Chiara Colombo; Carlo Morosi; Silvia Stacchiotti; Paolo G Casali; Angelo P Dei Tos; Silvana Pilotti
Journal:  Am J Surg Pathol       Date:  2015-03       Impact factor: 6.394

Review 2.  Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.

Authors:  Khin Thway
Journal:  Semin Diagn Pathol       Date:  2019-02-28       Impact factor: 3.464

Review 3.  Liposarcoma: Multimodality Management and Future Targeted Therapies.

Authors:  Aimee M Crago; Mark A Dickson
Journal:  Surg Oncol Clin N Am       Date:  2016-07-30       Impact factor: 3.495

4.  Differences in recurrence and survival of extremity liposarcoma subtypes.

Authors:  M Vos; H Koseła-Paterczyk; P Rutkowski; G J L H van Leenders; M Normantowicz; A Lecyk; S Sleijfer; C Verhoef; D J Grünhagen
Journal:  Eur J Surg Oncol       Date:  2018-04-06       Impact factor: 4.424

5.  Amputations for extremity soft tissue sarcoma in an era of limb salvage treatment: Local control and survival.

Authors:  Marc G Stevenson; Annelie H Musters; Jan H B Geertzen; Barbara L van Leeuwen; Harald J Hoekstra; Lukas B Been
Journal:  J Surg Oncol       Date:  2017-10-16       Impact factor: 3.454

6.  Metastasis in dedifferentiated liposarcoma: Predictors and outcome in 148 patients.

Authors:  S H Tirumani; H Tirumani; J P Jagannathan; A B Shinagare; J L Hornick; N H Ramaiya; A J Wagner
Journal:  Eur J Surg Oncol       Date:  2015-01-24       Impact factor: 4.424

7.  Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Margaret von Mehren; R Lor Randall; Robert S Benjamin; Sarah Boles; Marilyn M Bui; Kristen N Ganjoo; Suzanne George; Ricardo J Gonzalez; Martin J Heslin; John M Kane; Vicki Keedy; Edward Kim; Henry Koon; Joel Mayerson; Martin McCarter; Sean V McGarry; Christian Meyer; Zachary S Morris; Richard J O'Donnell; Alberto S Pappo; I Benjamin Paz; Ivy A Petersen; John D Pfeifer; Richard F Riedel; Bernice Ruo; Scott Schuetze; William D Tap; Jeffrey D Wayne; Mary Anne Bergman; Jillian L Scavone
Journal:  J Natl Compr Canc Netw       Date:  2018-05       Impact factor: 11.908

8.  Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study.

Authors:  V K Alamanda; S N Crosby; K R Archer; Y Song; H S Schwartz; G E Holt
Journal:  Eur J Surg Oncol       Date:  2012-09-15       Impact factor: 4.424

9.  Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.

Authors:  Francesco Muratori; Filippo Frenos; Leonardo Bettini; Davide Matera; Nicola Mondanelli; Maurizio Scorianz; Pierluigi Cuomo; Guido Scoccianti; Giovanni Beltrami; Daniela Greto; Lorenzo Livi; Giacomo Baldi; Giuliana Roselli; Rodolfo Capanna; Domenico Andrea Campanacci
Journal:  J Orthop Sci       Date:  2018-07-11       Impact factor: 1.601

Review 10.  Clinical and Molecular Spectrum of Liposarcoma.

Authors:  Alex Thomas John Lee; Khin Thway; Paul H Huang; Robin Lewis Jones
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.